跳至主要内容
临床试验/NCT03682757
NCT03682757已完成不适用

Post-Injury Platelet Biology: Mechanisms and Outcomes

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 367 人开始时间: 2018年9月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
367
试验地点
1
主要终点
In Vitro Measurement of Endothelial Biomarkers

研究概览

简要总结

Trauma-induced coagulopathy is a central cause of preventable deaths from hemorrhage after injury. The contribution and impact of altered post injury platelet biology on trauma-induced coagulopathy is not well understood despite the pivotal contribution of platelets to normal coagulation and endothelial integrity. The central hypothesis for this study is that severe injury and shock drive altered platelet activation, platelet aggregation, and platelet-endothelial interactions that are associated with increased rates of transfusion, organ failure, and mortality. This study will investigate these causal pathways, mechanisms, and associated outcomes in a prospective observational trauma cohort through collection of biospecimens and detailed clinical data.

详细描述

This is a prospective cohort study of trauma patients on admission to the emergency department and for the subsequent 28 days. All adult patients meeting criteria for full trauma team activation and admitted to Zuckerberg San Francisco General Hospital and Trauma center, a level-1 trauma center, are eligible for enrollment. A 20-ml sample of blood will be drawn within 10 minutes of arrival in the emergency department (ED), processed in the central laboratory, and plasma stored at -80°C. Blood samples will be collected immediately on presentation via initial placement of a 16-gauge or larger peripheral intravenous line. Plasma biomarkers of endothelial injury will be measured by enzyme-linked immunosorbent assays (von Willebrand factor, syndecan-1, and angiopoietin-2). Cellular biomarkers of platelet activation will be measured by flow cytometry (platelet-monocyte aggregates, integrin αIIbβ3, P-selectin, and platelet microparticles). Platelet aggregation will be measured by whole blood multiple electrode impedance aggregometry. The effect of post-injury platelets on endothelial integrity will be quantified by in vitro assays of platelet-induced endothelial permeability. Comprehensive demographic data and medical history will be collected from chart review, interviews of patients and family members. Detailed clinical and outcome data is collected including transfusion timing and doses, the incidence of organ failure (Denver Postinjury Multiple Organ Failure Score), acute respiratory distress syndrome (Berlin Definition), infection, symptomatic thromboembolic complications, ventilator-free days, length of intensive care unit (ICU) and hospital stay, and mortality (6 hours, 24 hours, 30 days). In hospital mortality after 30 days will be assessed for all patients. Standard coagulation measures (international normalized ratio, prothrombin time, platelet count) and other laboratory measures will be collected to account and control for other distinct but highly integrated pathways implicated in trauma-induced coagulopathy. The Trauma Registry, a large database managed under guidelines from the American Trauma society, uses chart review to retrospectively assign Injury Severity Scores (ISS) and Abbreviated Injury Scores (AIS).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients meeting criteria for full trauma team activation and admitted to Zuckerberg San Francisco General Hospital.

排除标准

  • Patients <18 years old
  • Patients transferred from other hospitals
  • Patients who are pregnant
  • Patients who are incarcerated
  • Patients will be retrospectively excluded if they were taking anticoagulant or anti-platelet medications, have moderate or severe liver disease, or a known bleeding diathesis.

结局指标

主要结局

In Vitro Measurement of Endothelial Biomarkers

时间窗: 0 hour (within 10 minutes of arrival to the Emergency Department)

Plasma biomarkers of endothelial injury will be measured by enzyme-linked immunosorbent assays (von Willebrand factor, syndecan-1, and angiopoietin-2).

Transfusion products received (red cell, plasma, platelet)

时间窗: in first 24 hours after arrival to the emergency department

Continuous units of red cell, plasma, platelet; transfused in 24 hours (yes/no); massive transfusion (\>10units red cell/24 hour, yes/no)

6-hour Mortality

时间窗: 6 hours after arrival to the emergency department

In Vitro Assays of Platelet-Induced Endothelial Permeability

时间窗: 0 hour (within 10 minutes of arrival to the Emergency Department)

The effect of post-injury platelets on endothelial integrity will be quantified by in vitro assays of platelet-induced endothelial permeability using transendothelial permeability electrical resistance (TEER) assays.

Organ Failure

时间窗: Within 1 week of arrival to the emergency department

Rates of organ failure (yes/no) (Denver Postinjury Multiple Organ Failure Score)

30-days Mortality

时间窗: 30 days after arrival to the emergency department

In Vitro Measurement Platelet Activation Biomarkers

时间窗: 0 hour (within 10 minutes of arrival to the Emergency Department)

Cellular biomarkers of platelet activation will be measured by flow cytometry (platelet-monocyte aggregates, integrin αIIbβ3, P-selectin, and platelet microparticles).

In Vitro Measurement of Platelet Aggregation

时间窗: 0 hour (within 10 minutes of arrival to the Emergency Department)

Platelet aggregation will be measured by whole blood multiple electrode impedance aggregometry.

24-hour Mortality

时间窗: 24 hours after arrival to the emergency department

Hospital Discharge Mortality

时间窗: Through hospital discharge (an average of 13 days)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验